Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | ELANE | P08246 | 3/20 | 0.41 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6353849 | 0.92 | ALDH1A1 (0.49) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL10414423 | 0.91 | HSD17B10 (0.55) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL30186912 | 0.88 | ALDH1A1 (0.63) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL2940838 | 0.88 | ALDH1A1 (0.63) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL268229 | 0.88 | ALDH1A1 (0.44) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL2942951 | 0.87 | ALDH1A1 (0.61) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL2528251 | 0.87 | ALDH1A1 (0.43) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL4823691 | 0.87 | ALDH1A1 (0.43) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL6159772 | 0.85 | ALDH1A1 (0.42) | ALDH1A1HSD17B10TSHRTDP1ELANE | |
| SCHEMBL2551419 | 0.84 | TDP1 (0.41) | ALDH1A1HSD17B10TSHRTDP1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210403701-A1 | CURABLE RESIN COMPOSITION, AND FILM, MOLDED ARTICLE, PREPREG, AND FIBER-REINFORCED PLASTIC USING SAID CURABLE RESIN COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-12-30 | — | — | US | claimed |
| WO-2009054621-A2 | THE COMPOSITION OF DECOLORABLE INK AND DECOLORING METHOD | HAN JONG-SOO (KR) | 2009-04-30 | — | — | WO | claimed |
| WO-2024232177-A1 | PHOTOCURABLE COMPOSITION, CURED PRODUCT THEREOF, AND MEMBER | ダイセル・オルネクス株式会社 | 2024-11-14 | — | — | WO | disclosed |
| WO-2024224903-A1 | CURABLE COMPOSITION, CURED PRODUCT THEREOF, AND LAYERED PRODUCT | ダイセル・オルネクス株式会社 | 2024-10-31 | — | — | WO | disclosed |
| WO-2024157637-A1 | LAMINATE AND IMAGE DISPLAY DEVICE | 株式会社ダイセル | 2024-08-02 | — | — | WO | disclosed |
| WO-2024135086-A1 | PHOTOCURABLE COMPOSITION, UNDERCOAT LAYER, LAMINATE AND DISPLAY DEVICE | 株式会社ダイセル | 2024-06-27 | — | — | WO | disclosed |
| CN-113840854-B | Resin composition, hard-coated film and polysilsesquioxane | 富士胶片株式会社 | 2024-05-14 | — | — | CN | disclosed |
| EP-4365916-A1 | INSULATED WIRE, COIL COMPRISING INSULATED WIRE, AND CABLE | Daicel Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024070846-A1 | CURABLE COMPOSITION | 株式会社ダイセル | 2024-04-04 | — | — | WO | disclosed |
| US-11932723-B2 | High-purity 3,4-epoxycyclohexylmethyl methacrylate | DAICEL CORPORATION (JP) | 2024-03-19 | — | — | US | disclosed |
| US-20240085784-A1 | ORGANIC EL DISPLAY DEVICE | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| EP-0260124-B1 | Transfer recording medium and process for production thereof | CANON KK (JP) | 1994-11-30 | — | — | EP | disclosed |
| EP-0363171-B1 | Method of and apparatus for forming volume type phase hologram | FUJITSU LTD (JP) | 1994-02-23 | — | — | EP | disclosed |
| US-5231440-A | Method of and apparatus for forming volume type phase hologram | FUJITSU LIMITED (JP) | 1993-07-27 | — | — | US | disclosed |
| US-5154994-A | Exposing holographic material of polymeric matrix with radiation active substance to interference pattern to form latent image, developing by dipping into swelling solution of solvent mixture, pulling, vaporizing solvents | FUJITSU LIMITED (JP) | 1992-10-13 | — | — | US | disclosed |
| US-5026590-A | Image forming element projecting from binder | CANON KABUSHIKI KAISHA (JP) | 1991-06-25 | — | — | US | disclosed |
| EP-0418870-A2 | Radiation sensitive polymer composition | TORAY INDUSTRIES, INC. (JP) | 1991-03-27 | — | — | EP | disclosed |
| EP-0363171-A2 | Method of and apparatus for forming volume type phase hologram | FUJITSU LIMITED (JP) | 1990-04-11 | — | — | EP | disclosed |
| US-4847110-A | IMAGES | CANON KABUSHIKI KAISHA (JP) | 1989-07-11 | — | — | US | disclosed |
| EP-0260124-A2 | Transfer recording medium and process for production thereof | CANON KABUSHIKI KAISHA (JP) | 1988-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11932723-B2 | High-purity 3,4-epoxycyclohexylmethyl methacrylate | MEP1A, MEP1B, FTO | ALDH1A1 409/4885HSD17B10 2775/4885TSHR 4862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.